Latest filing published 31 Mar 2026 for Soleno Therapeutics INC, €111k.
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Michael F. Huang discloses dealings in Soleno Therapeutics Inc to SEC (Form 4). The record holds 17 filings, for trades running from 17 July 2024 to 27 March 2026.
On the market, this insider has only sold: 12 sales, €1.1M in total. The rest of the record consists of 4 share grants and 1 option exercise. Since January 2026: no purchases and 3 sales on the market.
The latest filing, published on 31 March 2026, reports an open-market sale of €111k in Soleno Therapeutics Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations